Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Camptocormia: pathogenesis, classification, and response to therapy.

Shaheda N Azher1, Joseph Jankovic

  • 1Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.

Neurology
|August 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychogenic (Functional) Movement Disorders.

Continuum (Minneapolis, Minn.)·2019
Same author

Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.

Parkinsonism & related disorders·2019
Same author

Young-onset Parkinson's disease: Its unique features and their impact on quality of life.

Parkinsonism & related disorders·2019
Same author

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?

Frontiers in neurology·2019
Same author

Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.

Journal of the neurological sciences·2019
Same author

Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).

Molecular genetics & genomic medicine·2019

Camptocormia, a bent spine disorder, is linked to Parkinson disease and dystonia. Therapies like levodopa and botulinum toxin show variable effectiveness, suggesting multiple causes for this condition.

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Camptocormia, characterized by abnormal thoracolumbar spine flexion, was historically viewed as psychogenic.
  • It is increasingly recognized as a feature of parkinsonian and dystonic disorders.

Observation:

  • A study reviewed 16 patients with camptocormia, predominantly those with Parkinson disease (PD) and dystonia.
  • Patients exhibited a mean age of 64.9 years, with symptom onset around 51.5 years.

Findings:

  • Levodopa treatment yielded minimal improvement in camptocormia.
  • Botulinum toxin type A injections provided notable improvement in four out of nine patients.
  • Deep brain stimulation for PD did not improve camptocormia.

Implications:

Related Experiment Videos

  • Camptocormia is a heterogeneous disorder with multiple etiologies.
  • Treatment response varies, necessitating further research into its diverse causes and management strategies.